AKR1B1 抗体
(Aldo-Keto Reductase Family 1, Member B1 (Aldose Reductase) (AKR1B1))
This gene encodes a member of the aldo/keto reductase superfamily, which consists of more than 40 known enzymes and proteins. This member catalyzes the reduction of a number of aldehydes, including the aldehyde form of glucose, and is thereby implicated in the development of diabetic complications by catalyzing the reduction of glucose to sorbitol. Multiple pseudogenes have been identified for this gene. The nomenclature system used by the HUGO Gene Nomenclature Committee to define human aldo-keto reductase family members is known to differ from that used by the Mouse Genome Informatics database. [provided by RefSeq, Feb 2009].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| AKR1B1 抗体 (AA 241-290) | 人, 大鼠 | 兔 Polyclonal |
|
|
|
| AKR1B1 抗体 (AA 228-316) (APC) | 人, 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| AKR1B1 抗体 (AA 228-316) (Cy3) | 人, 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| AKR1B1 抗体 (AA 228-316) (Biotin) | 人, 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| AKR1B1 抗体 (AA 228-316) (HRP) | 人, 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| AKR1B1 抗体 (AA 228-316) (Fluoro594) | 人, 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| AKR1B1 抗体 (AA 228-316) (Fluoro550) | 人, 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| AKR1B1 抗体 (AA 228-316) | 人, 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| AKR1B1 抗体 (AA 228-316) (FITC) | 人, 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| AKR1B1 抗体 (AA 228-316) (Fluoro488) | 人, 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| AKR1B1 抗体 (AA 228-316) (Fluoro647) | 人, 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| AKR1B1 抗体 (AA 228-316) (PE) | 人, 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| AKR1B1 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| AKR1B1 抗体 (CF®740) | 人 | 小鼠 Monoclonal |
|
|
|
| AKR1B1 抗体 (CF®568) | 人 | 小鼠 Monoclonal |
|
|
|
| AKR1B1 抗体 (CF®647) | 人 | 小鼠 Monoclonal |
|
|
|
| AKR1B1 抗体 (CF®640R) | 人 | 小鼠 Monoclonal |
|
|
|
| AKR1B1 抗体 (CF®405S) | 人 | 小鼠 Monoclonal |
|
|
|
| AKR1B1 抗体 (Biotin) | 人 | 小鼠 Monoclonal |
|
|
|
| AKR1B1 抗体 (CF®594) | 人 | 小鼠 Monoclonal |
|
|
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 241-290
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人, 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- APC
- 抗体亚型
- IgG
- 抗原表位
- AA 228-316
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人, 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy3
- 抗体亚型
- IgG
- 抗原表位
- AA 228-316
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- AA 228-316
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- 抗原表位
- AA 228-316
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人, 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro594
- 抗体亚型
- IgG
- 抗原表位
- AA 228-316
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人, 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro550
- 抗体亚型
- IgG
- 抗原表位
- AA 228-316
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 质量等级
- Carrier-free
- 适用
- 人, 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 228-316
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人, 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- AA 228-316
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人, 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro488
- 抗体亚型
- IgG
- 抗原表位
- AA 228-316
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人, 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro647
- 抗体亚型
- IgG
- 抗原表位
- AA 228-316
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人, 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- PE
- 抗体亚型
- IgG
- 抗原表位
- AA 228-316
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- IHC (fp) (Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- CPTC-AKR1B1-3
- 标记
- CF®740
- 抗体亚型
- IgG1, kappa
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- IHC (fp) (Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- CPTC-AKR1B1-3
- 标记
- CF®568
- 抗体亚型
- IgG1, kappa
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- IHC (fp) (Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- CPTC-AKR1B1-3
- 标记
- CF®647
- 抗体亚型
- IgG1, kappa
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- IHC (fp) (Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- CPTC-AKR1B1-3
- 标记
- CF®640R
- 抗体亚型
- IgG1, kappa
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- IHC (fp) (Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- CPTC-AKR1B1-3
- 标记
- CF®405S
- 抗体亚型
- IgG1, kappa
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- IHC (fp) (Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- CPTC-AKR1B1-3
- 标记
- Biotin
- 抗体亚型
- IgG1, kappa
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- IHC (fp) (Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- CPTC-AKR1B1-3
- 标记
- CF®594
- 抗体亚型
- IgG1, kappa
Latest Publications for our AKR1B1 抗体
: "Investigation of synergistic mechanism and identification of interaction site of aldose reductase with the combination of gigantol and syringic acid for prevention of diabetic cataract." in: BMC complementary and alternative medicine, Vol. 16, Issue 1, pp. 286, (2017) (PubMed).
: "Quantitative Analysis of Differential Proteome Expression in Epithelial-to-Mesenchymal Transition of Bladder Epithelial Cells Using SILAC Method." in: Molecules (Basel, Switzerland), Vol. 21, Issue 1, pp. 84, (2016) (PubMed).
: "Induction of PGF2? synthesis by cortisol through GR dependent induction of CBR1 in human amnion fibroblasts." in: Endocrinology, Vol. 155, Issue 8, pp. 3017-24, (2014) (PubMed).
: "Proteomic analysis of rat proximal tubule cells following stretch-induced apoptosis in an in vitro model of kidney obstruction." in: Journal of proteomics, Vol. 100, pp. 125-35, (2014) (PubMed).
: "Identification of multiple and distinct defects in prostaglandin biosynthetic pathways in eutopic and ectopic endometrium of women with endometriosis." in: Fertility and sterility, Vol. 100, Issue 6, pp. 1650-9.e1-2, (2013) (PubMed).
: "Elevated extracellular glucose and uncontrolled type 1 diabetes enhance NFAT5 signaling and disrupt the transverse tubular network in mouse skeletal muscle." in: Experimental biology and medicine (Maywood, N.J.), Vol. 237, Issue 9, pp. 1068-83, (2012) (PubMed).
: "Proteasome inhibitors MG-132 and bortezomib induce AKR1C1, AKR1C3, AKR1B1, and AKR1B10 in human colon cancer cell lines SW-480 and HT-29." in: Chemico-biological interactions, Vol. 191, Issue 1-3, pp. 239-49, (2011) (PubMed).
: "Merging the binding sites of aldose and aldehyde reductase for detection of inhibitor selectivity-determining features." in: Journal of molecular biology, Vol. 379, Issue 5, pp. 991-1016, (2008) (PubMed).
: "Upregulation of aldose reductase during foam cell formation as possible link among diabetes, hyperlipidemia, and atherosclerosis." in: Arteriosclerosis, thrombosis, and vascular biology, Vol. 28, Issue 6, pp. 1137-43, (2008) (PubMed).
: "Quantitative Analysis of Differential Proteome Expression in Epithelial-to-Mesenchymal Transition of Bladder Epithelial Cells Using SILAC Method." in: Molecules (Basel, Switzerland), Vol. 21, Issue 1, pp. 84, (2016) (PubMed).
: "Induction of PGF2? synthesis by cortisol through GR dependent induction of CBR1 in human amnion fibroblasts." in: Endocrinology, Vol. 155, Issue 8, pp. 3017-24, (2014) (PubMed).
: "Proteomic analysis of rat proximal tubule cells following stretch-induced apoptosis in an in vitro model of kidney obstruction." in: Journal of proteomics, Vol. 100, pp. 125-35, (2014) (PubMed).
: "Identification of multiple and distinct defects in prostaglandin biosynthetic pathways in eutopic and ectopic endometrium of women with endometriosis." in: Fertility and sterility, Vol. 100, Issue 6, pp. 1650-9.e1-2, (2013) (PubMed).
: "Elevated extracellular glucose and uncontrolled type 1 diabetes enhance NFAT5 signaling and disrupt the transverse tubular network in mouse skeletal muscle." in: Experimental biology and medicine (Maywood, N.J.), Vol. 237, Issue 9, pp. 1068-83, (2012) (PubMed).
: "Proteasome inhibitors MG-132 and bortezomib induce AKR1C1, AKR1C3, AKR1B1, and AKR1B10 in human colon cancer cell lines SW-480 and HT-29." in: Chemico-biological interactions, Vol. 191, Issue 1-3, pp. 239-49, (2011) (PubMed).
: "Merging the binding sites of aldose and aldehyde reductase for detection of inhibitor selectivity-determining features." in: Journal of molecular biology, Vol. 379, Issue 5, pp. 991-1016, (2008) (PubMed).
: "Upregulation of aldose reductase during foam cell formation as possible link among diabetes, hyperlipidemia, and atherosclerosis." in: Arteriosclerosis, thrombosis, and vascular biology, Vol. 28, Issue 6, pp. 1137-43, (2008) (PubMed).
Aliases for AKR1B1 抗体
aldo-keto reductase family 1 member B (AKR1B1) 抗体aldo-keto reductase family 1 member B (Akr1b1) 抗体
aldo-keto reductase family 1, member B1 (aldose reductase) (AKR1B1) 抗体
aldo-keto reductase family 1, member B1 (aldose reductase) S homeolog (akr1b1.S) 抗体
aldo-keto reductase family 1, member B1 (aldose reductase) (akr1b1) 抗体
ADR 抗体
Akr1b3 抗体
Akr1b4 抗体
akr1b7 抗体
ALDR1 抗体
Aldr1 抗体
ALDRED 抗体
Alr 抗体
ALR-P-I 抗体
ALR2 抗体
AR 抗体
RATALDRED 抗体
zgc:86611 抗体
您还需要查找其他产品吗？
You are here:
